Found: 34
Select item for more details and to access through your institution.
Do levodopa treatments modify the morphology of the parkinsonian brain?
- Published in:
- Movement Disorders, 2012, v. 27, n. 1, p. 166, doi. 10.1002/mds.24018
- By:
- Publication type:
- Article
Oxygen and the Spark of Human Brain Evolution: Complex Interactions of Metabolism and Cortical Expansion across Development and Evolution.
- Published in:
- Neuroscientist, 2024, v. 30, n. 2, p. 173, doi. 10.1177/10738584221138032
- By:
- Publication type:
- Article
Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors.
- Published in:
- British Journal of Pharmacology, 2015, v. 172, n. 16, p. 4200, doi. 10.1111/bph.13208
- By:
- Publication type:
- Article
Application of Airy beam light sheet microscopy to examine early neurodevelopmental structures in 3D hiPSC-derived human cortical spheroids.
- Published in:
- Molecular Autism, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13229-021-00413-1
- By:
- Publication type:
- Article
Mice with Reduced Vesicular Monoamine Storage Content Display Nonmotor Features of Parkinson's Disease.
- Published in:
- Journal of Neuroscience, 2009, v. 29, n. 41, p. 12842, doi. 10.1523/JNEUROSCI.4156-09.2009
- By:
- Publication type:
- Article
Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
- Published in:
- Journal of Neurochemistry, 2007, v. 103, n. 3, p. 1075, doi. 10.1111/j.1471-4159.2007.04860.x
- By:
- Publication type:
- Article
Tissue optimization strategies for high‐quality ex vivo diffusion imaging.
- Published in:
- NMR in Biomedicine, 2023, v. 36, n. 3, p. 1, doi. 10.1002/nbm.4866
- By:
- Publication type:
- Article
Brain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies.
- Published in:
- Frontiers in Neurology, 2014, v. 5, p. 1, doi. 10.3389/fneur.2014.00095
- By:
- Publication type:
- Article
Microglial contribution to the pathology of neurodevelopmental disorders in humans.
- Published in:
- Acta Neuropathologica, 2023, v. 146, n. 5, p. 663, doi. 10.1007/s00401-023-02629-2
- By:
- Publication type:
- Article
Global brain volume reductions in a sub-chronic phencyclidine animal model for schizophrenia and their relationship to recognition memory.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Evolution of Extra-Nigral Damage Predicts Behavioural Deficits in a Rat Proteasome Inhibitor Model of Parkinson's Disease.
- Published in:
- PLoS ONE, 2011, v. 6, n. 2, p. 1, doi. 10.1371/journal.pone.0017269
- By:
- Publication type:
- Article
A unique cerebellar pattern of microglia activation in a mouse model of encephalopathy of prematurity.
- Published in:
- Glia, 2022, v. 70, n. 9, p. 1699, doi. 10.1002/glia.24190
- By:
- Publication type:
- Article
Simultaneous effects on parvalbumin-positive interneuron and dopaminergic system development in a transgenic rat model for sporadic schizophrenia.
- Published in:
- Scientific Reports, 2016, p. 34946, doi. 10.1038/srep34946
- By:
- Publication type:
- Article
Neuroprotection and Functional Recovery Associated with Decreased Microglial Activation Following Selective Activation of mGluR2/3 Receptors in a Rodent Model of Parkinson's Disease.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Neuroprotection and Functional Recovery Associated with DecreasedMicroglial Activation Following Selective Activation of mGluR2/3 Receptors in a RodentModel of Parkinson's Disease.
- Published in:
- Parkinson's Disease (20420080), 2011, p. 1, doi. 10.4061/2010/190450
- By:
- Publication type:
- Article
Neuroprotection and Functional Recovery Associated with Decreased Microglial Activation Following Selective Activation of mGluR2/3 Receptors in a Rodent Model of Parkinson's Disease.
- Published in:
- Parkinson's Disease (20420080), 2010, p. 1, doi. 10.4061/2010/190450
- By:
- Publication type:
- Article
Neuroanatomical and Microglial Alterations in the Striatum of Levodopa-Treated, Dyskinetic Hemi-Parkinsonian Rats.
- Published in:
- Frontiers in Neuroscience, 2020, v. 14, p. N.PAG, doi. 10.3389/fnins.2020.567222
- By:
- Publication type:
- Article
Striatal Volume Increase After Six Weeks of Selective Dopamine D<sub>2/3</sub> Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients.
- Published in:
- Frontiers in Neuroscience, 2020, v. 14, p. 1, doi. 10.3389/fnins.2020.00484
- By:
- Publication type:
- Article
Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses.
- Published in:
- Cellular & Molecular Life Sciences, 2022, v. 79, n. 8, p. 1, doi. 10.1007/s00018-022-04473-1
- By:
- Publication type:
- Article
A Role for Thalamic Projection GABAergic Neurons in Circadian Responses to Light.
- Published in:
- Journal of Neuroscience, 2022, v. 42, n. 49, p. 9158, doi. 10.1523/JNEUROSCI.0112-21.2022
- By:
- Publication type:
- Article
Individual behavioral trajectories shape whole-brain connectivity in mice.
- Published in:
- eLife, 2023, p. 1
- By:
- Publication type:
- Article
Magnetic resonance imaging and tensor-based morphometry in the MPTP non-human primate model of Parkinson’s disease.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0180733
- By:
- Publication type:
- Article
Characterization of the resting-state brain network topology in the 6-hydroxydopamine rat model of Parkinson’s disease.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0172394
- By:
- Publication type:
- Article
Erbb4 Deletion From Inhibitory Interneurons Causes Psychosis-Relevant Neuroimaging Phenotypes.
- Published in:
- Schizophrenia Bulletin, 2023, v. 49, n. 3, p. 569, doi. 10.1093/schbul/sbac192
- By:
- Publication type:
- Article
Corrigendum to: Normalizing the Abnormal: Do Antipsychotic Drugs Push the Cortex Into an Unsustainable Metabolic Envelope?
- Published in:
- Schizophrenia Bulletin, 2022, v. 48, n. 3, p. 721, doi. 10.1093/schbul/sbz139
- By:
- Publication type:
- Article
Normalizing the Abnormal: Do Antipsychotic Drugs Push the Cortex Into an Unsustainable Metabolic Envelope?
- Published in:
- Schizophrenia Bulletin, 2020, v. 46, n. 3, p. 484, doi. 10.1093/schbul/sbz119
- By:
- Publication type:
- Article
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-019-14122-0
- By:
- Publication type:
- Article
An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers.
- Published in:
- Human Brain Mapping, 2018, v. 39, n. 1, p. 319, doi. 10.1002/hbm.23844
- By:
- Publication type:
- Article
Effects of Antipsychotic Drugs: Cross Talk Between the Nervous and Innate Immune System.
- Published in:
- CNS Drugs, 2020, v. 34, n. 12, p. 1229, doi. 10.1007/s40263-020-00765-x
- By:
- Publication type:
- Article
Mapping the impact of exposure to maternal immune activation on juvenile Wistar rat brain macro- and microstructure during early post-natal development.
- Published in:
- Brain & Neuroscience Advances, 2019, v. 3, p. N.PAG, doi. 10.1177/2398212819883086
- By:
- Publication type:
- Article
Emerging Developments in Human Induced Pluripotent Stem Cell-Derived Microglia: Implications for Modelling Psychiatric Disorders With a Neurodevelopmental Origin.
- Published in:
- Frontiers in Psychiatry, 2020, p. N.PAG, doi. 10.3389/fpsyt.2020.00789
- By:
- Publication type:
- Article
Schizophrenia and Influenza at the Centenary of the 1918-1919 Spanish Influenza Pandemic: Mechanisms of Psychosis Risk.
- Published in:
- Frontiers in Psychiatry, 2020, p. 1, doi. 10.3389/fpsyt.2020.00072
- By:
- Publication type:
- Article
Brain volume in chronic ketamine users — relationship to sub-threshold psychotic symptoms and relevance to schizophrenia.
- Published in:
- Psychopharmacology, 2022, v. 239, n. 11, p. 3421, doi. 10.1007/s00213-021-05873-0
- By:
- Publication type:
- Article
Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease.
- Published in:
- BMC Neuroscience, 2010, v. 11, p. 1, doi. 10.1186/1471-2202-11-1
- By:
- Publication type:
- Article